Evidence map›Paper›PMID 42488108›Full record

ArticleFrontiers in oncology2026

MemSAM-2.5D: overcoming volumetric discontinuity and boundary ambiguity for 3D liver tumor segmentation.

Yinyin Hou, Ningning Chen, Tingting Huo, Weijia Wang

Abstract read
In one paragraph

Article in Frontiers in oncology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors.

Yinyin HouDepartment of Medical Oncology, Shaanxi Provincial People's Hospital, Xi'an, Shaanxi, China.
Ningning ChenDepartment of Medical Oncology, The First Affiliated Hospital of Xi'an Jiaotong University, Xi'an, Shaanxi, China.
Tingting HuoDepartment of Medical Oncology, Shaanxi Provincial People's Hospital, Xi'an, Shaanxi, China.
Weijia WangDepartment of Medical Oncology, Shaanxi Provincial People's Hospital, Xi'an, Shaanxi, China.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Introduction: Accurate segmentation of liver tumors from 3D computed tomography (CT) volumes is essential for the clinical management of hepatocellular carcinoma (HCC), but remains challenging because of extreme lesion-scale variation, volumetric discontinuity across slices, and ambiguous tumor boundaries. Methods: We propose MemSAM-2.5D, a unified 2.5D segmentation framework built upon the MedSAM foundation model. The framework integrates a Hybrid Mamba-Adapter (HMA) for intra-slice multi-scale representation, a Z-axis State Flow (ZSF) module for continuous inter-slice dependency modeling, and a Confidence-Gated Prototype Memory (CGPM) module for uncertainty-aware boundary refinement. Results: Extensive evaluations on MSD08, HCC-TACE-Seg, and WAW-TACE demonstrate that MemSAM-2.5D consistently outperforms representative CNN-based, Transformer-based, Mamba-based, and MedSAM-based baselines. The improvements are reflected not only in overlap-based metrics, but also in boundary-sensitive, lesion-level, and continuity-related measures. Discussion: These results suggest that coordinated modeling of multi-scale lesion variability, z-axis continuity, and boundary ambiguity provides an effective and transferable solution for clinically relevant HCC segmentation in CT volumes.

Indexed as

hepatocellular carcinomaliver tumor segmentationmedical image segmentationmemory networksstate space models

Identifiers

PMID42488108
PMCPMC13388144

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.